AASLD defines a direct financial relationship requiring disclosure as a compensated relationship of $5,000 or more, with a company, by an individual, that should generate an IRS Form W2-1099.

PANEL CHAIRS PERSONAL FINANCIAL RELATIONSHIP INSTITUTIONAL RESEARCH UPDATED DATE
Raymond T. Chung, MD None Dr Chung was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, MassBiologics, and Merck & Co, Inc. 10/21/15
Arthur Y. Kim, MD Dr Kim served on the advisory boards of AbbVie (ceased as of March 2014) and Bristol-Myers Squibb (ceased as of July 2014). Dr Kim was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, and Gilead Sciences, Inc. 11/20/15
Susanna Naggie, MD Dr Naggie served on an advisory board for Merck & Co, Inc (ceased as of September 2015). Dr Naggie was awarded research grants, paid to her institution, from AbbVie, Benitec Biopharma, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals. 11/16/15
Hugo E. Vargas, MD None Dr Vargas was awarded research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Mercks & Co, Inc. 09/29/15
PANEL MEMBERS PERSONAL FINANCIAL RELATIONSHIP INSTITUTIONAL RESEARCH UPDATED DATE
Andrew I. Aronsohn, MD None None 09/28/15
Debika Bhattacharya, MD None Dr Bhattacharya received study drugs, given to her institution, for research trials from AbbVie, Bristol-Myers Squibb, and Merck & Co, Inc. 10/20/15
Michael R. Charlton, MD Dr Charlton serves on the advisory boards of or as a consultant to AbbVie, Gilead Sciences, Inc, and Janssen Therapeutics, Inc. Dr Charlton was awarded research grants, paid to his institution, from Gilead Sciences, Inc, and Novartis International AG. 09/28/15
Robert J. Fontana, MD Dr Fontana served on a data and safety monitoring board for Tibotec Therapeutics. He serves as a consultant to Bristol-Myers Squibb. Dr Fontana was awarded research grants, paid to his institution, from Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Vertex Pharmaceuticals, Inc. 09/30/15
Eliot W. Godofsky, MD Dr Godofsky serves on the advisory boards of AbbVie, and Janssen Therapeutics, Inc. Dr Godofsky was awarded research grants, paid to his practice, from AbbVie, Achillion, Anadys, Boehringer Ingelheim Pharmaceuticals, Inc, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, Norvartis, and Vertex Pharmaceuticals, Inc. 09/28/15
Theo Heller, MD None None 10/20/15
Scott D. Holmberg, MD None None 10/20/15
Jennifer J. Kiser, PharmD None Dr Kiser was awarded research grants, paid to her institution, from Janssen Therapeutics, Inc, and ViiV Healthcare. 09/28/15
Shyam Kottilil, MD, PhD None None 09/28/15
Benjamin P. Linas, MD, MPH None None 10/08/15
Kristen Marks, MD None Dr Marks was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Merks & Co, Inc. 10/09/15
Paul Martin, MD Dr Martin serves on an advisory board for Bristol-Myers Squibb. Dr Martin was awarded research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Merck & Co, Inc. 09/29/15
Timothy R. Morgan, MD None Dr Morgan was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Merck & Co, Inc, and Roche. 09/30/15
Ronald G. Nahass, MD, MHCM, FACP, FIDSA Dr Nahass serves on advisory boards for Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. He also participates on speakers bureaus for and received honoraria from Bristol-Myers Squibb, Gilead Science, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. Dr Nahass was awarded research grants, paid to his institution, from Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. 10/20/15
Oluwaseun O. Falade-Nwulia, MBBS, MPH None Dr Falade-Nwulia’s was awarded research grants, paid to her institution, from Gilead Sciences, Inc. 10/20/15
Marion G. Peters, MD Dr Peters serves on the advisory boards of Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. None 10/11/15
Daniel Raymond None Mr Raymond’s organization was awarded educational grants from Genentech, Gilead Sciences, Inc, and Janssen Therapeutics, Inc. 01/14/15
Nancy Reau, MD Dr Reau serves on the advisory boards of AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck & Co, Inc. She has served as a consultant for Accordant. Dr Reau was awarded research grants, paid to her institution, from Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Inc, and Hyperion Therapeutics, Inc. 10/10/15
K. Rajender Reddy, MD Dr Reddy serves on advisory boards for AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc. He also receives royalties from UpToDate, Inc. Dr Reddy was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, GENFIT Corp, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Vertex Pharmaceuticals, Inc. 10/11/15
Andrew Reynolds None Mr Reynolds’s organization was awarded educational grants from AbbVie, Amgen, Bio-Rad Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Mercks & Co, Inc, OraSure Technologies, Inc, Roche, and Walgreens Co. 10/14/15
Michael S. Saag, MD None Dr Saag was awarded research grants, paid to his institution, from Abbvie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Merck & Co, Inc, and ViiV Healthcare. 05/04/15
John D. Scott, MD, MSc, FIDSA Dr Scott serves on a data and safety monitoring board for Tacere Therapeutics. He also serves as a consultant to Bristol-Myers Squibb, and Gilead Sciences, Inc. Dr Scott was awarded research grants from Merck & Co, Inc 10/20/15
Tracy Swan None Ms Swan’s organization was awarded educational grants from Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Mercks & Co, Inc, and ViiV Healthcare. 09/29/15
Norah A. Terrault, MD Dr Terrault serves on the advisory boards of AbbVie (uncompensated), Bristol-Myers Squibb, Gilead Sciences, Inc, (uncompensated), Merck & Co, Inc, and Pfizer She also serves as a consultant to Clinical Care Options, LLC, and UpToDate, Inc. Dr Terrault was awarded research grants, paid to her institution, from AbbVie, Biotest AG, Gilead Sciences, Inc, Novartis International AG, and Vertex Pharmaceuticals, Inc. 10/11/15
John B. Wong, MD None None 01/20/15
David L. Wyles, MD Dr Wyles serves on the advisory board of AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Janssen Therapeutics, Inc. Dr Wyles was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Merck & Co, Inc, Tacere Therapeutics, and Vertex Pharmaceuticals, Inc. 10/08/15